Do Smokers Stick to Cancer Screening Guidelines?

MedicalResearch.com Interview with:

Nina Niu Sanford, M.D. Assistant ProfessorUT Southwestern Department of Radiation OncologyDallas TX 75390

Dr. Sanford

Nina Niu Sanford, M.D. 
Assistant Professor
UT Southwestern Department of Radiation Oncology
Dallas TX 75390 

MedicalResearch.com: What is the background for this study? What are the main findings?

Response: The background of this study is that smoking is associated with increased risk for multiple cancer types, although the most commonly noted association is between smoking and lung cancer – because of this, lung cancer screening guidelines have been established for current smokers and those who have recently quit.

What is less well known is whether patients who smoke are more or less likely to adhere to screening guidelines for other cancer types.

MedicalResearch.com: What is the background for this study? What are the main findings? 

Response: In this study, we found that current smokers were less likely to adhere to national screening guidelines for prostate, breast and colorectal cancer, as compared to never smokers. 

MedicalResearch.com: What should readers take away from your report? 

Response: That smokers are less likely to undergo age appropriate cancer screening for several major cancer types.  This is important because they are at baseline higher risk for these cancers thus without screening, would be more likely to present at advanced stage.  We know that current smoking is a risk factor for worse cancer-specific outcomes, and delayed diagnosis could be one of the contributing factors.

MedicalResearch.com: What recommendations do you have for future research as a result of this work?

Response: Further research is needed to identify the barriers to cancer screening among individuals who smoke, such that initiatives can be undertaken to increase uptake of cancer screening among this population.

Citation:

Sanford NN, Sher DJ, Butler S, et al. Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015. JAMA Netw Open. 2019;2(5):e193759. doi:10.1001/jamanetworkopen.2019.3759

 

May 19, 2019 @ 6:32 pm

 

 

 

The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.

 

Varenicline – Chantix – Helped More Smokers Quit Gradually

Jon Ebbert, M.D. Associate director for research Mayo Clinic Nicotine Dependence CenterMedicalResearch.com Interview with:
Jon Ebbert, M.D.

Associate director for research
Mayo Clinic Nicotine Dependence Center

 

Medical Research: What is the background for this study? What are the main findings?

Dr. Ebbert: Some cigarette smokers prefer to reduce the number cigarettes that they smoke before quitting smoking completely. Previous studies have evaluated the use of nicotine replacement therapy and one smaller study looked at varenicline to help smokers quit through smoking reduction. We wanted to conduct a larger study with varenicline using a longer duration of treatment.

We enrolled cigarette smokers who had no intention of quitting in the next month but who were willing to reduce the number of cigarettes they smoked while working toward a quit attempt in the next 3 months.

Continue reading

Genes Influence Body Weight in Smokers and Never-Smokers

Marcus Munafò PhD Professor of Biological Psychology MRC Integrative Epidemiology Unit UK Centre for Tobacco and Alcohol Studies School of Experimental Psychology University of Bristol United KingdomMedicalResearch.com Interview with:
Marcus Munafò PhD
Professor of Biological Psychology
MRC Integrative Epidemiology Unit
UK Centre for Tobacco and Alcohol Studies
School of Experimental Psychology
University of Bristol United Kingdom

Medical Research: What is the background for this study? What are the main findings?

Dr. Munafo: We were conducting an analysis of data on smoking behaviour and body mass index (BMI), in order to better understand the potential causal effects of smoking on different measures of adiposity. Mendelian randomisation uses genetic variants associated with the exposure of interest (in this case smoking) as proxies for the exposure, in order to reduce the risk of spurious associations arising from confounding or reverse causality. As expected, we found that, among current smokers, a genetic variant associated with heavier smoking was associated with lower BMI, providing good evidence that smoking reduces BMI. However, we also unexpectedly found that the same variant was associated with higher BMI in never smokers. This suggests that this variant might be influencing BMI via pathways other than smoking.
Continue reading

Smokers’ Homes Have High Air Pollution Levels

Dr. John Cherrie PhD Honorary Professor in Occupational Hygiene Institute of Applied Health Sciences Aberdeen, UKMedicalResearch.com Interview with:
Dr. John Cherrie PhD
Honorary Professor in Occupational Hygiene
Institute of Applied Health Sciences
Aberdeen, UK


Medical Research: What are the main findings of the study?

Dr. Cherrie: We set out to bring together measurements of fine particle levels in homes where smoking takes place, to compare these with smoke-free homes and then to estimate how much of these fine particles are inhaled by people at different stages in their life. We also wanted to look at the exposure to particles of non-smokers living with smokers and compare this with the exposure of people living in heavily polluted major cities around the world.
Continue reading